Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model
Eggermont et al. 2020. European Journal of Cancer.
Eggermont et al. 2020. European Journal of Cancer.
Bellomo et al. 2020. JCO Precision Oncology.